David C. Hanley - 01 Jun 2021 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Chief Technical Operations
Signature
David C. Hanley, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
03 Jun 2021, 18:36:29 UTC
Next filing
02 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +250,000 $0.000000 250,000 01 Jun 2021 Class A Common Stock 250,000 $13.60 Direct F1
transaction NUVB Stock Option (Right to Buy) Award $0 +187,500 $0.000000 187,500 01 Jun 2021 Class A Common Stock 187,500 $13.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on June 1, 2022 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
F2 The shares subject to the Options will vest based on the satisfaction of both time-based and performance-based vesting criteria.